Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best Melanotan-2 Dosage for Libido: Comparison Table

0.25–0.5mg daily Mild increase in sexual desire; noticeable arousal threshold reduction after 3–5 days 3–4 hours / 6 hours Minimal. Mild flushing in 15–20% Lowest dose range tested in Phase II female arousal trials Ideal starting point for dose titration; allo

This comparison does not assign a generated winner or score.

  • 0.25–0.5mg daily
  • Mild increase in sexual desire; noticeable arousal threshold reduction after 3–5 days
  • 3–4 hours / 6 hours
  • Minimal. Mild flushing in 15–20%
  • Lowest dose range tested in Phase II female arousal trials
  • Ideal starting point for dose titration; allows individual response assessment without overshooting therapeutic window
  • 0.5–1.0mg daily
  • Moderate to significant libido enhancement; spontaneous sexual thoughts increase; improved arousal response to stimuli
  • 2–3 hours / 6–8 hours
  • Nausea (20–30%), facial flushing (40%), mild tanning after 7–10 days
  • Most commonly used dose in published sexual dysfunction trials; highest efficacy-to-side-effect ratio
  • Sweet spot for most individuals. Delivers meaningful sexual function improvement while keeping melanocortin side effects manageable
  • 1.0–1.5mg daily
  • Maximal sexual arousal effect; plateau in libido gains; spontaneous erections common in men
  • 2–3 hours / 8 hours
  • Nausea (40–50%), moderate tanning, appetite suppression, spontaneous erections (men)
  • Upper therapeutic range in clinical trials; side effects begin to limit tolerability
  • Therapeutic ceiling. Doses above this range produce proportionally greater side effects without additional sexual benefit
  • 1.5–2.0mg daily
  • No additional sexual function benefit beyond 1.0–1.5mg; side effect burden increases sharply
  • 2 hours / 8–10 hours
  • Nausea (50–60%), significant tanning, prolonged erections (8–12% in men), marked appetite suppression
  • Tested in dose-escalation studies; higher discontinuation rates due to adverse events
  • Not recommended for libido-focused protocols. Risk exceeds benefit; side effects dominate the experience
  • >2.0mg daily
  • No documented sexual function advantage; severe melanocortin side effects
  • Variable
  • Severe nausea, vomiting, priapism risk, rapid pigmentation, significant appetite loss
  • Outside the range tested in formal sexual dysfunction trials
  • Unwarranted. No clinical rationale for doses above 2mg when the therapeutic target is sexual function
More references

Related material